P
Paracel Explorer
Dernière publication·Octobre 2026

Skyrizi

Risankizumabum — sol inj 180 mg/1.2 ml

AbbVie AG

ATCL04AC18
Swissmedic68946
Dossier21718
Remboursement
QP 10%PMKG
Modifications (10)